Global Cervical Cancer Cases Could Reach 1.08 Million by 2050, Deaths May Exceed 522,000

Cervical cancer is expected to become an increasingly serious global health challenge over the coming decades, with the number of new cases and deaths projected to rise significantly by 2050. Women in sub-Saharan Africa are likely to face the greatest impact, according to a new international study.

Researchers examined cervical cancer trends across 204 countries and territories, analysing cases, deaths and the overall health burden between 1990 and 2023. They also used the findings to estimate how the disease could develop over the next 25 years.

The analysis found that approximately 887,000 women were diagnosed with cervical cancer worldwide in 2023, while around 369,000 deaths were recorded during the same year.

However, the outlook for 2050 is concerning. Annual new cases could increase to approximately 1.08 million, representing a rise of 20.2 per cent compared with 2024. Meanwhile, yearly deaths are projected to grow by 39.3 per cent, reaching an estimated 522,000.

Sub-Saharan Africa Faces the Greatest Increase

The study identified sub-Saharan Africa as the region likely to experience the steepest rise in cervical cancer cases and deaths.

By 2050, new cases in the region could increase by 88.7 per cent, while deaths may rise by 95.4 per cent. The annual death toll could reach approximately 206,000, highlighting the growing pressure on healthcare systems across the region.

Global Elimination Target Remains Out of Reach

The researchers warned that current disease trends could prevent all seven regions included in the analysis from achieving the global cervical cancer elimination target by 2050.

The elimination benchmark requires countries to reduce new cervical cancer cases to fewer than four per 100,000 women annually. Reaching this level would mean the disease is no longer considered a major public health problem.

Vaccination and Early Detection Remain Essential

The findings underline the importance of expanding vaccination against human papillomavirus (HPV), the main cause of cervical cancer. Researchers also stressed the need for wider screening programmes, earlier diagnosis and improved access to effective treatment.

However, access to these essential healthcare services remains uneven across countries, particularly in areas with limited medical resources.

Poorer Countries Carry a Heavier Burden

The study also revealed a major gap between low-income and high-income countries.

In 2023, the age-standardised rate of new cervical cancer cases in low-income countries was more than four times higher than in wealthier nations. The mortality rate was even more unequal, with low-income countries recording rates more than seven times higher.

These differences highlight the urgent need for stronger prevention programmes, affordable screening and better treatment facilities, especially in countries where healthcare access remains limited.

Without significant improvements in vaccination, early detection and medical care, cervical cancer could continue to claim hundreds of thousands of lives every year.

Please follow and like us:
WP2Social Auto Publish Powered By : XYZScripts.com